





 Introduction:  Studies suggest that severely obese women (BMI > 35) suffer more frequent severe menopausal symptoms than their non-obese counterparts.  For some women, the severity of symptoms, coupled with obesity, has been strongly correlated with negative quality of life, severe enough that women often seek medical treatment.   Few studies have been done to evaluate the effect of bariatric surgery, a major weight loss procedure, on relief of menopausal symptoms.  The purpose of this study was to compare the severity of hot flashes and vaginal dryness in severely obese women pre- and post-bariatric surgery to determine if the severity and prevalence of the symptoms decreased after significant weight loss. 
Methods:  This study focuses on women participating in the Barimark Study who filled out reproductive history forms, which included questions about menopausal symptoms, at the baseline and first follow-up visits.  Participants rated symptom severity on a scale of 1 (not bothersome) to 5 (extremely bothersome).  Anthropometric measurements were obtained pre- and post-operatively at Magee-Womens Hospital.  Participants were divided into two age groups (< 35 years and >35 years) for the purpose of statistical analysis.  Presence of symptoms and symptom severity at pre- and post-surgery were compared using McNemar’s test and Wilcoxon signed-rank test.
Results:  Ninety-two women (age 22 – 72 years) participated in this study.  Women < 35 years reported no hot flashes and there was no change in the prevalence of hot flashes in either age group.  There was a significant reduction in severity of hot flashes in women aged >35 years (p<0.01).  There were significant reductions in both prevalence (p=0.03) and severity of vaginal dryness (p=0.02) in women aged <35 years.  While we did not have sufficient numbers to explore relationships between hormone use, hysterectomy, hysterectomy plus oophorectomy, and change in weight to the change in symptom severity, preliminary data suggested that there is no statistically significant relationship between the change in symptom severity and the above covariates.  
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Menopausal symptoms, specifically hot flashes and vaginal dryness, are experienced by 50-80% of menopausal women. ADDIN EN.CITE  HYPERLINK \l "_ENREF_1" \o "Nelson, 2008 #40" 1,  Approximately 29% of women report persistent hot flashes and 33% vaginal dryness. ADDIN EN.CITE  HYPERLINK \l "_ENREF_1" \o "Nelson, 2008 #40" 1,  For many women, these symptoms can be severe enough to interfere with daily life. ADDIN EN.CITE 4  Among obese women (body mass index (BMI > 30), recent studies suggest that menopausal symptoms are more severe and occur more frequently compared to normal weight (BMI 18-25) women. ADDIN EN.CITE 5  Vasomotor symptoms, specifically hot flashes, can become so severe that the negative impact on quality of life ADDIN EN.CITE 6 causes many women to seek medical treatment. HYPERLINK \l "_ENREF_1" \o "Nelson, 2008 #40"  ADDIN EN.CITE <EndNote><Cite><Author>Nelson</Author><Year>2008</Year><RecNum>40</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>40</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">40</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nelson, H. D.</author></authors></contributors><auth-address>Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, OR, USA. nelsonh@ohsu.edu</auth-address><titles><title>Menopause</title><secondary-title>Lancet</secondary-title><alt-title>Lancet</alt-title></titles><periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></periodical><alt-periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></alt-periodical><pages>760-70</pages><volume>371</volume><number>9614</number><edition>2008/03/04</edition><keywords><keyword>Adult</keyword><keyword>Aging/*physiology/psychology</keyword><keyword>Amines/*therapeutic use</keyword><keyword>Cyclohexanecarboxylic Acids/*therapeutic use</keyword><keyword>*Estrogen Replacement Therapy</keyword><keyword>Female</keyword><keyword>Hot Flashes/*drug therapy/etiology</keyword><keyword>Humans</keyword><keyword>Menopause/drug effects/*physiology/psychology</keyword><keyword>Middle Aged</keyword><keyword>Randomized Controlled Trials as Topic</keyword><keyword>gamma-Aminobutyric Acid/*therapeutic use</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>0140-6736</isbn><accession-num>18313505</accession-num><urls></urls><electronic-resource-num>10.1016/s0140-6736(08)60346-3</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>1  Additionally, recent studies demonstrate that a high adiposity and BMI are associated with an increase in reported hot flashes. ADDIN EN.CITE  HYPERLINK \l "_ENREF_2" \o "Gold, 2006 #84" 2,  The underlying mechanisms of hot flashes are not completely understood, but likely involve both thermoregulatory models and endocrine factors.  One thermoregulatory model is based on the hypothesis that obese women experience decreased heat tolerance.  Excess adipose tissue acts as insulating material, reducing heat dissipation HYPERLINK \l "_ENREF_10" \o "Anderson, 1999 #30"  ADDIN EN.CITE <EndNote><Cite><Author>Anderson</Author><Year>1999</Year><RecNum>30</RecNum><DisplayText><style face="superscript">10</style></DisplayText><record><rec-number>30</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">30</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anderson, G. S.</author></authors></contributors><auth-address>University College of the Fraser Valley, Mission, BC, Canada. andersong@ucfv.bc.ca</auth-address><titles><title>Human morphology and temperature regulation</title><secondary-title>Int J Biometeorol</secondary-title><alt-title>International journal of biometeorology</alt-title></titles><periodical><full-title>Int J Biometeorol</full-title><abbr-1>International journal of biometeorology</abbr-1></periodical><alt-periodical><full-title>Int J Biometeorol</full-title><abbr-1>International journal of biometeorology</abbr-1></alt-periodical><pages>99-109</pages><volume>43</volume><number>3</number><edition>2000/01/20</edition><keywords><keyword>Adipose Tissue/anatomy &amp; histology</keyword><keyword>Adult</keyword><keyword>Animals</keyword><keyword>Body Constitution/*physiology</keyword><keyword>Body Temperature Regulation/*physiology</keyword><keyword>Cold Temperature</keyword><keyword>Hot Temperature</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Meteorological Concepts</keyword><keyword>Muscle, Skeletal/anatomy &amp; histology</keyword></keywords><dates><year>1999</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0020-7128 (Print)&#xD;0020-7128</isbn><accession-num>10639901</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>10,  and resulting in the increased frequency of hot flashes to dissipate excess heat. HYPERLINK \l "_ENREF_11" \o "Haymes, 1975 #39"  ADDIN EN.CITE <EndNote><Cite><Author>Haymes</Author><Year>1975</Year><RecNum>39</RecNum><DisplayText><style face="superscript">11</style></DisplayText><record><rec-number>39</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">39</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Haymes, E. M.</author><author>McCormick, R. J.</author><author>Buskirk, E. R.</author></authors></contributors><titles><title>Heat tolerance of exercising lean and obese prepubertal boys</title><secondary-title>J Appl Physiol</secondary-title><alt-title>Journal of applied physiology</alt-title></titles><periodical><full-title>J Appl Physiol</full-title><abbr-1>Journal of applied physiology</abbr-1></periodical><alt-periodical><full-title>J Appl Physiol</full-title><abbr-1>Journal of applied physiology</abbr-1></alt-periodical><pages>457-61</pages><volume>39</volume><number>3</number><edition>1975/09/01</edition><keywords><keyword>Adult</keyword><keyword>Age Factors</keyword><keyword>*Body Temperature Regulation</keyword><keyword>Child</keyword><keyword>Female</keyword><keyword>Heart Rate</keyword><keyword>*Hot Temperature</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Obesity/*physiopathology</keyword><keyword>Oxygen Consumption</keyword><keyword>*Physical Exertion</keyword><keyword>Sex Factors</keyword><keyword>Skin Temperature</keyword><keyword>Sweating</keyword></keywords><dates><year>1975</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0021-8987 (Print)&#xD;0021-8987</isbn><accession-num>1176412</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>11    Another thermoregulatory model explains increased hot flashes based on a narrowed thermoneutral zone in obese women.  The thermoneutral zone is the temperature set points between sweating and shivering.  The body tries to maintain the core temperature within a comfortable thermoneutral zone.  When the core temperature rises above the upper threshold of this zone, sweating occurs; when the core temperature falls below the lower threshold of this zone, shivering occurs. HYPERLINK \l "_ENREF_12" \o ", 2005 #76"  ADDIN EN.CITE <EndNote><Cite><Year>2005</Year><RecNum>76</RecNum><DisplayText><style face="superscript">12</style></DisplayText><record><rec-number>76</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">76</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors></contributors><titles><title>Menospause: Why some women get hot flashes and others don&apos;t</title></titles><dates><year>2005</year></dates><publisher>Harvard Health Publications Harvard Medical School</publisher><urls><related-urls><url>http://www.health.harvard.edu/press_releases/menopause_hot_flashes</url></related-urls></urls></record></Cite></EndNote>12   Women with a wider thermoneutral zone would experience a greater range in core temperatures before sweating or shivering occurs; women with a narrower thermoneutral zone would experience a smaller range in core temperatures before sweating or shivering occurs.  Due to mechanisms that are not clearly understood, this zone becomes very narrow in obese women, which causes an increase in sweating via hot flashes. HYPERLINK \l "_ENREF_13" \o "Freedman, 2002 #64"  ADDIN EN.CITE <EndNote><Cite><Author>Freedman</Author><Year>2002</Year><RecNum>64</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>64</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">64</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freedman, R. R.</author></authors></contributors><titles><title>Hot flash trends and mechanisms</title><secondary-title>Menopause</secondary-title><alt-title>Menopause (New York, N.Y.)</alt-title></titles><periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></alt-periodical><pages>151-2</pages><volume>9</volume><number>3</number><edition>2002/04/26</edition><keywords><keyword>*Body Temperature</keyword><keyword>Estrogen Replacement Therapy</keyword><keyword>Female</keyword><keyword>Hot Flashes/drug therapy/epidemiology/*etiology</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Postmenopause</keyword></keywords><dates><year>2002</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1072-3714 (Print)&#xD;1072-3714</isbn><accession-num>11973436</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>13  
Endocrine factors are also implicated in hot flashes in obese women.  Literature suggests that premenopausal and perimenopausal obese women have lower estrogen levels ADDIN EN.CITE 14-16 than their normal weight counterparts, which may lead to the increase in hot flashes. ADDIN EN.CITE  HYPERLINK \l "_ENREF_8" \o "Gallicchio, 2005 #37" 8,  Specifically, both estradiol and estrone levels are lower in obese women. HYPERLINK \l "_ENREF_18" \o "Klinga, 1983 #63"  ADDIN EN.CITE <EndNote><Cite><Author>Klinga</Author><Year>1983</Year><RecNum>63</RecNum><DisplayText><style face="superscript">18</style></DisplayText><record><rec-number>63</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">63</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Klinga, K.</author><author>von Holst, T.</author><author>Runnebaum, B.</author></authors></contributors><titles><title>Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women</title><secondary-title>Eur J Obstet Gynecol Reprod Biol</secondary-title><alt-title>European journal of obstetrics, gynecology, and reproductive biology</alt-title></titles><periodical><full-title>Eur J Obstet Gynecol Reprod Biol</full-title><abbr-1>European journal of obstetrics, gynecology, and reproductive biology</abbr-1></periodical><alt-periodical><full-title>Eur J Obstet Gynecol Reprod Biol</full-title><abbr-1>European journal of obstetrics, gynecology, and reproductive biology</abbr-1></alt-periodical><pages>103-12</pages><volume>15</volume><number>2</number><edition>1983/06/01</edition><keywords><keyword>Adult</keyword><keyword>Androstenedione/blood</keyword><keyword>Climacteric</keyword><keyword>Estrone/blood</keyword><keyword>Female</keyword><keyword>Follicle Stimulating Hormone/blood</keyword><keyword>Gonadal Steroid Hormones/*blood</keyword><keyword>Humans</keyword><keyword>Luteinizing Hormone/blood</keyword><keyword>*Menopause</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*blood</keyword><keyword>Pituitary Hormones, Anterior/*blood</keyword><keyword>Testosterone/blood</keyword></keywords><dates><year>1983</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0301-2115 (Print)&#xD;0301-2115</isbn><accession-num>6409684</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>18  
1.2	vaginal dryness
Generally, vaginal dryness is linked to low concentrations of estrogens and androgens.  Vaginal dryness has been linked to vulvovaginal atrophy resulting from estrogen deficiency and affecting a large number of postmenopausal women. HYPERLINK \l "_ENREF_19" \o "Ibe, 2010 #36"  ADDIN EN.CITE <EndNote><Cite><Author>Ibe</Author><RecNum>36</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="p0psprvs8v0wpsexda8v2wz2rzp0pfaf20zw">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ibe, Comfort</author><author>Simon, James A.</author></authors></contributors><titles><title>Continuing Medical Education: Vulvovaginal Atrophy: Current and Future Therapies (CME)</title><secondary-title>J  Sexual Medicine</secondary-title></titles><periodical><full-title>J  Sexual Medicine</full-title></periodical><pages>1042-1050</pages><volume>7</volume><number>3</number><dates><year>2010</year></dates><isbn>3</isbn><urls><related-urls><url>doi: 10.1111/j.1743-6109.2009.01692.x</url></related-urls></urls></record></Cite></EndNote>19  The vaginal response to these lowered concentrations include:  reduced secretions, tissue changes, and pH changes from acidic to neutral fluids. HYPERLINK \l "_ENREF_1" \o "Nelson, 2008 #40"  ADDIN EN.CITE <EndNote><Cite><Author>Nelson</Author><Year>2008</Year><RecNum>40</RecNum><DisplayText><style face="superscript">1</style></DisplayText><record><rec-number>40</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">40</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nelson, H. D.</author></authors></contributors><auth-address>Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, OR, USA. nelsonh@ohsu.edu</auth-address><titles><title>Menopause</title><secondary-title>Lancet</secondary-title><alt-title>Lancet</alt-title></titles><periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></periodical><alt-periodical><full-title>Lancet</full-title><abbr-1>Lancet</abbr-1></alt-periodical><pages>760-70</pages><volume>371</volume><number>9614</number><edition>2008/03/04</edition><keywords><keyword>Adult</keyword><keyword>Aging/*physiology/psychology</keyword><keyword>Amines/*therapeutic use</keyword><keyword>Cyclohexanecarboxylic Acids/*therapeutic use</keyword><keyword>*Estrogen Replacement Therapy</keyword><keyword>Female</keyword><keyword>Hot Flashes/*drug therapy/etiology</keyword><keyword>Humans</keyword><keyword>Menopause/drug effects/*physiology/psychology</keyword><keyword>Middle Aged</keyword><keyword>Randomized Controlled Trials as Topic</keyword><keyword>gamma-Aminobutyric Acid/*therapeutic use</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>0140-6736</isbn><accession-num>18313505</accession-num><urls></urls><electronic-resource-num>10.1016/s0140-6736(08)60346-3</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>1  In normal premenopausal women, glycogen-derived glucose is metabolized into lactic acid which helps maintain a vaginal pH of 3.5 to 4.5.  As estrogen-dependent glycogen levels decrease during peri- and post-menopausal phases, exfoliation of the vaginal epithelium decreases, resulting in reduced normal lactobacilli flora, and vaginal pH increases. HYPERLINK \l "_ENREF_20" \o "Stute, 2013 #67"  ADDIN EN.CITE <EndNote><Cite><Author>Stute</Author><Year>2013</Year><RecNum>67</RecNum><DisplayText><style face="superscript">20</style></DisplayText><record><rec-number>67</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">67</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stute, P.</author></authors></contributors><auth-address>Department of Obstetrics and Gynecology, Inselspital Bern, Effingerstrasse 102, 3010, Bern, Switzerland, petra.stute@insel.ch.</auth-address><titles><title>Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?</title><secondary-title>Arch Gynecol Obstet</secondary-title><alt-title>Archives of gynecology and obstetrics</alt-title></titles><periodical><full-title>Arch Gynecol Obstet</full-title><abbr-1>Archives of gynecology and obstetrics</abbr-1></periodical><alt-periodical><full-title>Arch Gynecol Obstet</full-title><abbr-1>Archives of gynecology and obstetrics</abbr-1></alt-periodical><pages>1199-201</pages><volume>288</volume><number>6</number><edition>2013/11/02</edition><dates><year>2013</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0932-0067</isbn><accession-num>24178484</accession-num><urls></urls><electronic-resource-num>10.1007/s00404-013-3068-5</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>20  The increase in vaginal pH and thinning of the vaginal epithelium leads to vulvovaginal symptoms, of which vaginal dryness/itching are the most common. ADDIN EN.CITE  HYPERLINK \l "_ENREF_20" \o "Stute, 2013 #67" 20,  Vaginal symptoms are also associated with medications (i.e. anitdepressants), medical conditions (i.e. obesity, diabetes), and behavioral factors (i.e. smoking).  Literature indicates that obesity is correlated with circulating levels of sex hormones, independent of age. HYPERLINK \l "_ENREF_22" \o "Freeman, 2010 #36"  ADDIN EN.CITE <EndNote><Cite><Author>Freeman</Author><Year>2010</Year><RecNum>36</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freeman, E. W.</author><author>Sammel, M. D.</author><author>Lin, H.</author><author>Gracia, C. R.</author></authors></contributors><auth-address>Department of Obstetrics/Gynecology, University of Pennsylvania, Philadelphia, PA, USA. freemane@mail.med.upenn.edu</auth-address><titles><title>Obesity and reproductive hormone levels in the transition to menopause</title><secondary-title>Menopause</secondary-title><alt-title>Menopause (New York, N.Y.)</alt-title></titles><periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></alt-periodical><pages>718-26</pages><volume>17</volume><number>4</number><edition>2010/03/11</edition><keywords><keyword>Adult</keyword><keyword>Body Mass Index</keyword><keyword>Estradiol/*blood</keyword><keyword>Female</keyword><keyword>Follicle Stimulating Hormone/*blood</keyword><keyword>Humans</keyword><keyword>Inhibins/*blood</keyword><keyword>Linear Models</keyword><keyword>Longitudinal Studies</keyword><keyword>Menopause/*blood</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*blood</keyword><keyword>Waist Circumference</keyword><keyword>Waist-Hip Ratio</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1072-3714</isbn><accession-num>20216473</accession-num><urls></urls><custom2>Pmc2888623</custom2><custom6>Nihms181076</custom6><electronic-resource-num>10.1097/gme.0b013e3181cec85d</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>22  Research has indicated that obese, premenopausal women not only have lower levels of estrogens, but also have decreased levels of sex-hormone binding globulin (SHBG). ADDIN EN.CITE  HYPERLINK \l "_ENREF_23" \o "Akin, 2008 #29" 23,  One hypothesis explaining vaginal dryness in premenopausal women is based on decreased levels of SHBG, which is directly linked to lower levels of circulating estrogens HYPERLINK \l "_ENREF_22" \o "Freeman, 2010 #36"  ADDIN EN.CITE <EndNote><Cite><Author>Freeman</Author><Year>2010</Year><RecNum>36</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freeman, E. W.</author><author>Sammel, M. D.</author><author>Lin, H.</author><author>Gracia, C. R.</author></authors></contributors><auth-address>Department of Obstetrics/Gynecology, University of Pennsylvania, Philadelphia, PA, USA. freemane@mail.med.upenn.edu</auth-address><titles><title>Obesity and reproductive hormone levels in the transition to menopause</title><secondary-title>Menopause</secondary-title><alt-title>Menopause (New York, N.Y.)</alt-title></titles><periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></alt-periodical><pages>718-26</pages><volume>17</volume><number>4</number><edition>2010/03/11</edition><keywords><keyword>Adult</keyword><keyword>Body Mass Index</keyword><keyword>Estradiol/*blood</keyword><keyword>Female</keyword><keyword>Follicle Stimulating Hormone/*blood</keyword><keyword>Humans</keyword><keyword>Inhibins/*blood</keyword><keyword>Linear Models</keyword><keyword>Longitudinal Studies</keyword><keyword>Menopause/*blood</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*blood</keyword><keyword>Waist Circumference</keyword><keyword>Waist-Hip Ratio</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1072-3714</isbn><accession-num>20216473</accession-num><urls></urls><custom2>Pmc2888623</custom2><custom6>Nihms181076</custom6><electronic-resource-num>10.1097/gme.0b013e3181cec85d</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>22; therefore, leading to lower levels of glycogen, and changes in vaginal pH and epithelial density.  Conversely, in obese, post-menopausal women, levels of estrogens are actually higher. ADDIN EN.CITE 24  This can be attributed to the conversions of androgens into estrogens, specifically estrone, via aromatase found in adipose tissue.  Therefore, increased estrogen levels may correlate with increased glycogen levels, leading to an acidic vaginal pH, which results in a decrease of vaginal symptoms.
1.3	OBESITY
Obesity has been rapidly increasing in the United States HYPERLINK \l "_ENREF_22" \o "Freeman, 2010 #36"  ADDIN EN.CITE <EndNote><Cite><Author>Freeman</Author><Year>2010</Year><RecNum>36</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freeman, E. W.</author><author>Sammel, M. D.</author><author>Lin, H.</author><author>Gracia, C. R.</author></authors></contributors><auth-address>Department of Obstetrics/Gynecology, University of Pennsylvania, Philadelphia, PA, USA. freemane@mail.med.upenn.edu</auth-address><titles><title>Obesity and reproductive hormone levels in the transition to menopause</title><secondary-title>Menopause</secondary-title><alt-title>Menopause (New York, N.Y.)</alt-title></titles><periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></periodical><alt-periodical><full-title>Menopause</full-title><abbr-1>Menopause (New York, N.Y.)</abbr-1></alt-periodical><pages>718-26</pages><volume>17</volume><number>4</number><edition>2010/03/11</edition><keywords><keyword>Adult</keyword><keyword>Body Mass Index</keyword><keyword>Estradiol/*blood</keyword><keyword>Female</keyword><keyword>Follicle Stimulating Hormone/*blood</keyword><keyword>Humans</keyword><keyword>Inhibins/*blood</keyword><keyword>Linear Models</keyword><keyword>Longitudinal Studies</keyword><keyword>Menopause/*blood</keyword><keyword>Middle Aged</keyword><keyword>Obesity/*blood</keyword><keyword>Waist Circumference</keyword><keyword>Waist-Hip Ratio</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1072-3714</isbn><accession-num>20216473</accession-num><urls></urls><custom2>Pmc2888623</custom2><custom6>Nihms181076</custom6><electronic-resource-num>10.1097/gme.0b013e3181cec85d</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>22, and as of 2012, 34.9% of adults were classified as obese (BMI > 30). ADDIN EN.CITE <EndNote><Cite><Year>2014</Year><RecNum>70</RecNum><DisplayText><style face="superscript">25,26</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">70</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors></contributors><titles><title>Centers for Disease Control and Prevention.  Adult obesity facts</title></titles><dates><year>2014</year></dates><urls><related-urls><url>http://www.cdc.gov/obesity/data/adult.html</url></related-urls></urls></record></Cite><Cite><Year>2013</Year><RecNum>71</RecNum><record><rec-number>71</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">71</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors></contributors><titles><title>World Health Organization.  Obesity and overweight&#xD;</title></titles><dates><year>2013</year></dates><urls><related-urls><url>http://www.who.int/mediacentre/factsheets/fs311/en/</url></related-urls></urls></record></Cite></EndNote> HYPERLINK \l "_ENREF_25" \o ", 2014 #70" 25,  In 2008, the United States spent $147 billion on obesity related medical conditions. HYPERLINK \l "_ENREF_25" \o ", 2014 #70"  ADDIN EN.CITE <EndNote><Cite><Year>2014</Year><RecNum>70</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>70</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">70</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors></contributors><titles><title>Centers for Disease Control and Prevention.  Adult obesity facts</title></titles><dates><year>2014</year></dates><urls><related-urls><url>http://www.cdc.gov/obesity/data/adult.html</url></related-urls></urls></record></Cite></EndNote>25  Obesity has been strongly associated with increased risk for cardiovascular disease, hypertension, diabetes, sleep apnea, cancer, and premature death.  Among women, obesity is strongly linked to endometrial cancer (EC), the most common gynecologic malignancy, where the risk of EC is two to four times that observed in non-obese women. HYPERLINK \l "_ENREF_27" \o ", 2012 #77"  ADDIN EN.CITE <EndNote><Cite><Year>2012</Year><RecNum>77</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>77</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">77</key></foreign-keys><ref-type name="Interview">64</ref-type><contributors></contributors><titles><title>National Cancer Institute.  Obesity and Cancer Risk</title></titles><dates><year>2012</year></dates><urls><related-urls><url>http://www.cancer.gov/cancertopics/factsheet/Risk/obesity</url></related-urls></urls></record></Cite></EndNote>27  The National Cancer Institute predicts that the continued rates of obesity will result in 500,000 new cases of cancer by 2030 in the United States. HYPERLINK \l "_ENREF_27" \o ", 2012 #77"  ADDIN EN.CITE <EndNote><Cite><Year>2012</Year><RecNum>77</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>77</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">77</key></foreign-keys><ref-type name="Interview">64</ref-type><contributors></contributors><titles><title>National Cancer Institute.  Obesity and Cancer Risk</title></titles><dates><year>2012</year></dates><urls><related-urls><url>http://www.cancer.gov/cancertopics/factsheet/Risk/obesity</url></related-urls></urls></record></Cite></EndNote>27  
As established above, obesity plays a major role in the development of menopausal symptoms.  Therefore, the debilitating effects of obesity, combined with severe menopausal symptoms have the potential to negatively impact the daily lives of women to the extent that they seek medical treatment.  Numerous studies have shown that weight loss improves health, lowers the risk for many chronic diseases, and improves quality of life. ADDIN EN.CITE  HYPERLINK \l "_ENREF_4" \o "Fine, 1999 #35" 4,,   Research has been done on the treatments for obesity, but no clear agreement has emerged on a particular method.  Treatments range from behavioral modifications (diet and exercise) to surgical interventions (bariatric surgery). ADDIN EN.CITE 29  The RENEW Study evaluated the efficacy of diet and exercise on the adverse health effects of severe obesity, ADDIN EN.CITE 30 with the key finding that behavioral modification was successful resulting in clinically significant weight loss. HYPERLINK \l "_ENREF_31" \o "Goodpaster, 2010 #79"  ADDIN EN.CITE <EndNote><Cite><Author>Goodpaster</Author><Year>2010</Year><RecNum>79</RecNum><DisplayText><style face="superscript">31</style></DisplayText><record><rec-number>79</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">79</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goodpaster, B. H.</author><author>DeLany, J. P.</author><author>Otto, A. D.</author><author>et al.,</author></authors></contributors><titles><title>Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults</title><secondary-title>JAMA</secondary-title></titles><periodical><full-title>Jama</full-title><abbr-1>JAMA : the journal of the American Medical Association</abbr-1></periodical><pages>1795-1802</pages><volume>304</volume><number>16</number><dates><year>2010</year></dates><isbn>16</isbn><urls></urls></record></Cite></EndNote>31  Linkov et al, reported that this significant weight loss in RENEW participants resulted in decreased levels of cancer-associated biomarkers. ADDIN EN.CITE 30  








Ninety-two female bariatric surgery candidates from the bariatric surgery clinic of Magee-Womens Hospital of the University of Pittsburgh Medical Center (UPMC) aged 22 to 72 were included in this preliminary analysis if they met the following inclusion criteria:  women approved for and scheduled for bariatric surgery (Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, or sleeve gastrectomy), and completed health surveys at baseline and six month post-operative follow-up visits.  Self-reported data were obtained from reproductive and general health questionnaires administered at both visits.  Exclusion criteria included:  refusal to sign informed consent, refusal or inability to complete anthropometric measurements and paper based questionnaires, and inability to attend baseline and follow-up visits.  Study procedures were overseen by professional research staff in the Clinical and Translational Research Center (CTRC) at Magee-Womens Hospital of UPMC.


2.2    MEASURES






2.3    STATISTICAL METHODS


For description of the study population, continuous variables are reported as median (range); categorical variables are reported as n (%).  Women were first classified into two age categories:  < 35 years and >35 years; then the statistical comparisons of symptom presence and severity between baseline and first follow-up visits were performed using McNemar’s test.  McNemar’s test is used to compare differences in paired data.  Mean symptom severity at pre- and post-surgery was also computed as a continuous average of the scale rating systems from 1 (not bothersome) to 5 (extremely bothersome) and both Wilcoxon signed-rank test and paired t-test was used to compare the scores.  Statisical analysis was conducted using




3.0    RESULTS


Table 1 lists the baseline characteristics of study participants.  The median age was 45.5 years (range: 22 -72), the median weight was 121.5 kg (range: 87.5 – 175.7), and the median BMI was 45.1 kg/m2 (range: 35.0 – 61.1).  The median weight loss was 31.9 kg (range:  0.53-55.9) and the median post-operative BMI was 34.3 (range:  24.0 – 50.9).  In women age <35 years, 39.1% reported hormone use (includes HT, birth control, fertility drugs), 5.6% reported hysterectomy alone, 5.6 % reported hysterectomy/oophorectomy, none reported hot flashes, and 47.8% reported vaginal dryness.  In the women aged >35 years, 27.7% reported hormone use, 6.4% reported hysterectomy alone, 26.2% reported hysterectomy/oophorectomy, 38.5% reported hot flashes, and 41.3% reported vaginal dryness.  
Table 2 compares the reporting of hot flashes and vaginal dryness between the baseline and first-follow-up visit.  There were no changes in those reporting hot flashes in either age group; no women reported hot flashes at either time point in the <35 years group.  In the >35 age group, the same 25 women reported hot flashes at the baseline and at the follow-up visit.  There were significant changes in vaginal dryness, however.  In the <35 age group, 7 women that had reported vaginal dryness at the baseline visit did not do so at the follow-up visit, while only 1 did the opposite, indicative of a significant group-wide decrease in vaginal dryness (p=0.03).  A similar pattern was observed in the >35 age group, with 7 women that had reported vaginal dryness at the baseline visit no longer doing so a the follow-up visit, while only 2 did the opposite; however, this did not reach conventional statistical significance p<0.05 (p=0.09).
Table 3 compares the severity of symptoms on a scale of 1 to 5 (none/not bothersome to extremely bothersome), and the mean severity of symptoms between baseline and first follow-up visits by age group.  There was a significant decrease in severity of hot flashes after bariatric surgery in the >35 age group using both the Wilcoxon test (p<0.01) and the paired t-test (p<0.01).   The decrease in vaginal dryness severity in the <35 age group was also significant (p=0.02 for Wilcoxon test and p=0.01 for paired t-test); however, there was no significant change in the >35 age group (p>0.05 for both Wilcoxon and paired t-test).  We do not have sufficient numbers of participants to assess the relationships of hormone use, hysterectomy, hysterectomy plus oophorectomy, and change in weight to the change in severity of symptoms before and after bariatric surgery.  The preliminary data indicates there are no significant associations between these covariates and the change in symptom severity.


4.0    DISCUSSION


Among a cohort of 92 women that underwent bariatric surgery who had baseline and six month post-operative visits, hot flash and vaginal dryness severity decreased six months after bariatric surgery.  Specifically, though we showed no reduction in the prevalence of hot flashes, we did find that hot flash severity decreased in women age >35 years.  We also found both prevalence and severity of vaginal dryness decreased in women age <35 years.  For the preliminary data, we did not find significant associations between hormone use, hysterectomy, hysterectomy plus oophorectomy, change in weight, and reported change in symptom severity.
As obesity continues to be an increasing public health concern, it is vital to determine the underlying comorbidities that are aggravated by obesity.  Bariatric surgery significantly reduced hot flash and vaginal dryness severity, which, for many women, are associated with a negative impact on daily life, such as low self-esteem, depression, low physical activity. HYPERLINK \l "_ENREF_28" \o "Rand, 1990 #43"  ADDIN EN.CITE <EndNote><Cite><Author>Rand</Author><Year>1990</Year><RecNum>43</RecNum><DisplayText><style face="superscript">28</style></DisplayText><record><rec-number>43</rec-number><foreign-keys><key app="EN" db-id="vssrvzt5lwwpa3e0ewbvsfw5vpr9e90aexx2">43</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rand, C. S.</author><author>Macgregor, A. M.</author></authors></contributors><auth-address>Department of Psychiatry, University of Florida, Gainesville 32610-0256.</auth-address><titles><title>Morbidly obese patients&apos; perceptions of social discrimination before and after surgery for obesity</title><secondary-title>South Med J</secondary-title><alt-title>Southern medical journal</alt-title></titles><periodical><full-title>South Med J</full-title><abbr-1>Southern medical journal</abbr-1></periodical><alt-periodical><full-title>South Med J</full-title><abbr-1>Southern medical journal</abbr-1></alt-periodical><pages>1390-5</pages><volume>83</volume><number>12</number><edition>1990/12/01</edition><keywords><keyword>Adult</keyword><keyword>Affect</keyword><keyword>Attitude of Health Personnel</keyword><keyword>*Attitude to Health</keyword><keyword>Evaluation Studies as Topic</keyword><keyword>Humans</keyword><keyword>Interpersonal Relations</keyword><keyword>Middle Aged</keyword><keyword>Obesity, Morbid/*psychology/surgery</keyword><keyword>*Prejudice</keyword><keyword>Prospective Studies</keyword><keyword>Questionnaires</keyword><keyword>Self Concept</keyword><keyword>Sex Factors</keyword><keyword>Social Perception</keyword><keyword>Weight Loss/physiology</keyword></keywords><dates><year>1990</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0038-4348 (Print)&#xD;0038-4348</isbn><accession-num>2251527</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>28   To the best of our knowledge, no other studies have specifically looked at the change in menopausal symptoms before and after bariatric surgery; therefore, our study is the first to focus on morbidly obese women undergoing bariatric surgery, and look at the change in symptom severity pre- and post-operatively.  
The major strength of this study is the prospective assessment of symptom severity and prevalence change in obese females undergoing a procedure to reduce weight, bariatric surgery, over time in a prospective study.  The study is important because it provides empirical data supporting the hypothesized relationship between weight and menopausal symptoms and the association between weight loss and attenuation of severe hot flashes and vaginal dryness.  Future studies will require larger samples and a longer follow-up period to determine the extent to which decreases in symptom severity, such as those reported here, are associated with long-term weight loss.  
However, the study findings should be considered in the context of several key limitations.  First, this population is very specific:  morbidly obese women undergoing bariatric surgery, and is not representative of the general population.  Second, symptom severity was self-reported and measured on a subjective scale of 1 to 5 (1 not bothersome to 5 extremely bothersome).  What may be not bothersome to one woman may be interpreted as extremely bothersome to another woman.  However, this classification has been used in several large, multi-site trials with success. ADDIN EN.CITE 37  
While hot flashes and vaginal dryness are not diagnosable diseases, these symptoms cause major discomfort and have negative effects on quality of life.  Future directions for research include understanding of the underlying mechanisms of hot flashes and how these symptoms are aggravated by obesity.  Severe hot flashes are frequently reported as a result of chemotherapy, and severity is strongly associated with increased BMI; ADDIN EN.CITE  HYPERLINK \l "_ENREF_40" \o "Savard, 2009 #46" 40,  therefore, this may have implications for cancer research.  Weight loss may be a valid treatment to reduce severity of hot flashes.  In addition, recognition and treatment of these symptoms in obese women should be considered as vital components of their health and guidelines for treatment need to be developed.

















Age (years)   median  (range)     < 35 years   n (%)     > 35 years  	45.5  (22 – 72)   23  (25.0)    69  (75.0)
BMI (kg/m2)  median  (range)	45.1  (35.0 – 61.1)
Weight (kilograms)  median  (range)	121.5  (87.5 – 175.7)
Self-reported  menopausal status by age category  n (%)   < 35 years      Pre-menopausal      Perimenopausal       Post-menopausal (natural)      Post-menopausal (surg/med)   >35 years      Pre-menopausal      Perimenopausal      Post-menopausal (natural)      Post-menopausal (surg/med)	21  (95.5)  0    0  1  (4.6)23  (33.9)12  (18.5)17  (26.2)14  (21.5)
Any Hormone Use by Age Category  n  (%)     < 35 years         Yes              No          No Response     >35 years        Yes         No         No Response	  9  (39.1)14  (60.9)  018  (26.1)47  (68.1)  4  (5.8)






Hysterectomy/Oophorectomy  n  (%)   < 35 years       Yes       No       No Response    >35 years      Yes       No       No Response	  1  (4.3)17 (73.9)  5  (21.7)17  (24.6)48  (69.6)  4  (5.8)
Hot Flashes  n  (%)   < 35 years       Yes       No       No Response   >35 years       Yes       No       No Response	  021  (91.3)  2  (8.7)25  (36.2)40  (58.0)  4  (5.8)




























































asix month post-operative visit








Table 3:  Prevalence of the severity of symptoms     n = 92
Symptom severity  n  (%)	Baseline	First follow-upa	p-valueb	Baselinec	First follow-upd	p-valuee
Hot Flashes   <35 years        >35 years1  None/Not Bothersome2 Somewhat Bothersome3 Moderately Bothersome4 Severely Bothersome5 Extremely Bothersome	 0    3  (12.0)9  (36.0)5  (20.0)5  (20.0)3  (12.0)	 0  11  (42.3)11  (42.3)  2  (7.7)  1  (3.9)  1  (3.9)	NAp<0.01	01.73 (1.43-2.03)	01.33 (1.14-1.53)	NAp<0.01
Vaginal Dryness   <35 years1 None/Not Bothersome2 Somewhat Bothersome3 Moderately Bothersome4 Severely Bothersome5 Extremely Bothersome   >35 years1 None/Not Bothersome2  Somewhat Bothersome3 Moderately Bothersome4  Severely Bothersome5  Extremely Bothersome	 2  (18.2) 4  (36.4) 2  (18.2) 3  (27.3) 0  4  (15.4)12  46.2)  5 (19.2)  4 (15.4)  1  (3.9) 	 2  (40.0) 2  (40.0) 1  (20.0) 0 0   6  (28.6)  5  (23.8)  8  (38.1)  1  (4.8)  1  (4.8)	0.020.37	1.73(1.27–2.21)1.62(1.37–1.88)	1.17(0.96–1.37)1.45(1.23–1.69)	0.010.29
asix month post-operative visit
bp-values from Wilcoxon signed-rank test
cMean severity at baseline visit:  mean (95% CI)
dMean severity at first follow-up visit:  mean (95% CI)
ep-values from paired t-test
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